{"schema_version":"1","generated_at":"2026-11-05T14:18:55.727Z","data_as_of":null,"url":"https://www.findmykol.com/kol/philip-haddad","json_url":"https://www.findmykol.com/kol/philip-haddad/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"philip-haddad","name":"Philip Haddad","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Overton Brooks VA Medical Center","institution_url":"https://www.findmykol.com/institution/overton-brooks-va-medical-center","city":"Shreveport","state":"LA","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1427056456","orcid":"0000-0003-4094-069X","openalex":"A5038677483"},"summary":"Philip Haddad is an Oncology physician affiliated with Overton Brooks VA Medical Center. OpenAlex indexes 132 publications with 266 citations (h-index 4).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":132,"cited_by_count":266,"h_index":4,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":4,"shown":3,"withheld":1,"rows":[{"payer":"Genentech","program_year":2025,"amount_usd":12280,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1427056456"},{"payer":"AstraZeneca","program_year":2024,"amount_usd":400,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1427056456"},{"payer":"Acrotech Biopharma","program_year":2022,"amount_usd":6318.64,"payment_count":7,"source_url":"https://openpaymentsdata.cms.gov/search?query=1427056456"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1427056456","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Clinicopathologic Features and Survival Determinants of Hepatosplenic T‐Cell Lymphoma: A Pooled Patient‐Level Dataset Analysis","year":2026,"journal":"Hematological Oncology","source_url":"https://doi.org/10.1002/hon.70271","status":"verified"},{"title":"The Role of Stem Cell Transplantation and the Determinants of Survival In Primary Cutaneous Gamma-Delta T-cell Lymphoma (PCGDTCL): Analysis of a Pooled Database","year":2026,"journal":"Transplantation and Cellular Therapy","source_url":"https://doi.org/10.1016/j.jtct.2026.02.034","status":"verified"},{"title":"The Role of Stem Cell Transplantation In Hepatosplenic T-cell Lymphoma and Its Associated Survival Determinants: Analysis of an Updated Real-World Database","year":2026,"journal":"Transplantation and Cellular Therapy","source_url":"https://doi.org/10.1016/j.jtct.2026.02.032","status":"verified"},{"title":"Abstract 34: Attitudes and perception of artificial intelligence in healthcare: A cross-sectional survey among Arkansas-Louisiana-Texas (ArkLATX) veterans with cancer.","year":2026,"journal":"Cancer Research","source_url":"https://doi.org/10.1158/1538-7445.am2026-34","status":"verified"},{"title":"Abstract 6653: Hepatosplenic T-cell lymphoma gamma-delta versus alpha-beta: A comparative study of clinicopathologic features and outcomes.","year":2026,"journal":"Cancer Research","source_url":"https://doi.org/10.1158/1538-7445.am2026-6653","status":"verified"}],"source":"works"},"similar":[{"name":"Roxana Baluna","slug":"roxana-baluna","institution":"Overton Brooks VA Medical Center","specialty":"Radiation Oncology","url":"https://www.findmykol.com/kol/roxana-baluna","json_url":"https://www.findmykol.com/kol/roxana-baluna/profile.json"},{"name":"Surender Arora","slug":"surender-arora","institution":"Overton Brooks VA Medical Center","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/surender-arora","json_url":"https://www.findmykol.com/kol/surender-arora/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":1,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}